These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8898858)
1. Targeted neutralization of calmodulin in the nucleus blocks DNA synthesis and cell cycle progression. Wang J; Moreira KM; Campos B; Kaetzel MA; Dedman JR Biochim Biophys Acta; 1996 Oct; 1313(3):223-8. PubMed ID: 8898858 [TBL] [Abstract][Full Text] [Related]
2. Temporal inhibition of calmodulin in the nucleus. King KL; Moreira KM; Babcock GF; Wang J; Campos B; Kaetzel MA; Dedman JR Biochim Biophys Acta; 1998 Dec; 1448(2):245-53. PubMed ID: 9920415 [TBL] [Abstract][Full Text] [Related]
3. [The regulation of calmodulin in the cell cycle]. Jin S; Yin L; Wang DS; Liu HT Shi Yan Sheng Wu Xue Bao; 1995 Jun; 28(2):121-9. PubMed ID: 7571946 [TBL] [Abstract][Full Text] [Related]
4. Role of the N-terminal region of the skeletal muscle myosin light chain kinase target sequence in its interaction with calmodulin. Findlay WA; Gradwell MJ; Bayley PM Protein Sci; 1995 Nov; 4(11):2375-82. PubMed ID: 8563635 [TBL] [Abstract][Full Text] [Related]
6. Solution X-ray scattering data show structural differences among chimeras of yeast and chicken calmodulin: implications for structure and function. Yokouchi T; Nogami H; Izumi Y; Yoshino H; Nakashima K; Yazawa M Biochemistry; 2003 Feb; 42(7):2195-201. PubMed ID: 12590609 [TBL] [Abstract][Full Text] [Related]
7. Functional elimination of calmodulin within the nucleus by targeted expression of an inhibitor peptide. Wang J; Campos B; Jamieson GA; Kaetzel MA; Dedman JR J Biol Chem; 1995 Dec; 270(51):30245-8. PubMed ID: 8530438 [TBL] [Abstract][Full Text] [Related]
8. Variable conformation and dynamics of calmodulin complexed with peptides derived from the autoinhibitory domains of target proteins. Yao Y; Squier TC Biochemistry; 1996 May; 35(21):6815-27. PubMed ID: 8639633 [TBL] [Abstract][Full Text] [Related]
9. Rational design of new binding specificity by simultaneous mutagenesis of calmodulin and a target peptide. Green DF; Dennis AT; Fam PS; Tidor B; Jasanoff A Biochemistry; 2006 Oct; 45(41):12547-59. PubMed ID: 17029410 [TBL] [Abstract][Full Text] [Related]
10. Construction of an epitope-tagged calmodulin useful for the analysis of calmodulin-binding proteins: addition of a hemagglutinin epitope does not affect calmodulin-dependent activation of smooth muscle myosin light chain kinase. Szymanska G; O'Connor MB; O'Connor CM Anal Biochem; 1997 Oct; 252(1):96-105. PubMed ID: 9324946 [TBL] [Abstract][Full Text] [Related]
11. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin. Ohki S; Ikura M; Zhang M Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027 [TBL] [Abstract][Full Text] [Related]
12. Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Rodriguez-Mora OG; LaHair MM; McCubrey JA; Franklin RA Cancer Res; 2005 Jun; 65(12):5408-16. PubMed ID: 15958590 [TBL] [Abstract][Full Text] [Related]
13. Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity. Shoemaker MO; Lau W; Shattuck RL; Kwiatkowski AP; Matrisian PE; Guerra-Santos L; Wilson E; Lukas TJ; Van Eldik LJ; Watterson DM J Cell Biol; 1990 Sep; 111(3):1107-25. PubMed ID: 2202734 [TBL] [Abstract][Full Text] [Related]
14. Systematic delineation of a calmodulin peptide interaction. Hultschig C; Hecht HJ; Frank R J Mol Biol; 2004 Oct; 343(3):559-68. PubMed ID: 15465045 [TBL] [Abstract][Full Text] [Related]
15. Further insights into calmodulin-myosin light chain kinase interaction from solution scattering and shape restoration. Heller WT; Krueger JK; Trewhella J Biochemistry; 2003 Sep; 42(36):10579-88. PubMed ID: 12962481 [TBL] [Abstract][Full Text] [Related]
16. Expression of a calmodulin inhibitor peptide in progenitor alveolar type II cells disrupts lung development. Wang J; Campos B; Kaetzel MA; Dedman JR Am J Physiol; 1996 Aug; 271(2 Pt 1):L245-50. PubMed ID: 8770063 [TBL] [Abstract][Full Text] [Related]
17. Calmodulin-mediated cell cycle regulation: new mechanisms for old observations. Choi J; Husain M Cell Cycle; 2006 Oct; 5(19):2183-6. PubMed ID: 16969097 [TBL] [Abstract][Full Text] [Related]
18. Peptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formation. Hui S; Choi J; Zaidi S; Momen A; Steinbach SK; Sadi AM; Ban K; Husain M Circ Res; 2011 Apr; 108(9):1053-62. PubMed ID: 21372285 [TBL] [Abstract][Full Text] [Related]
19. Investigating the high affinity and low sequence specificity of calmodulin binding to its targets. Afshar M; Caves LS; Guimard L; Hubbard RE; Calas B; Grassy G; Haiech J J Mol Biol; 1994 Dec; 244(5):554-71. PubMed ID: 7990140 [TBL] [Abstract][Full Text] [Related]
20. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74. Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]